Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors

This study has been withdrawn prior to enrollment.
(PI (Prof. Slavin) not longer work at Hadassah)
Sponsor:
Collaborator:
The International Center for Cell Therapy & Cancer Immunotherapy (CTCI)
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00148993
First received: September 7, 2005
Last updated: April 7, 2011
Last verified: July 2005
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: July 2005
  Estimated Primary Completion Date: No date given